Results 321 to 330 of about 199,652 (389)
Some of the next articles are maybe not open access.
Progressive Systemic Sclerosis
Annals of Internal Medicine, 1978Excerpt To the editor: Data in a recent article on Sjogren's syndrome in scleroderma by Cipoletti and associates (Ann Intern Med87:535-541, 1977) apparently differ enough from ours (1) to cite us i...
openaire +2 more sources
Progressive Systemic Sclerosis
Clinics in Rheumatic Diseases, 1983To date, largely because of convenience, therapeutic trials in progressive systemic sclerosis have been few and largely short-term retrospective single institution studies. For the future, there is a pressing need to expand efforts in this area to include: controlled, prospective studies with adequate numbers of patients employing, if necessary, a ...
openaire +3 more sources
Progressive Systemic Sclerosis (Scleroderma)
Australasian Annals of Medicine, 1970SummarySixteen cases of progressive systemic sclerosis (PSS) were studied in a large general hospital in Singapore from 1957 to 1967. Thirteen were Chinese and 3 Malays. The majority were middle‐aged housewives and half of the cases were seen less than six months after onset.
Oon Teik Khoo, Chong Hai Tay
openaire +3 more sources
Progressive systemic sclerosis and the lung
Current Opinion in Pulmonary Medicine, 1998Pulmonary manifestations of systemic sclerosis (scleroderma) are many. The mean survival in these patients is 78 +/- 17 months. Improved diagnostic techniques and better therapeutic options are essential to stem the tide of overwhelming mortality in patients with scleroderma lung disease.
Om P. Sharma, Srihari Veeraraghavan
openaire +3 more sources
Arthritis & Rheumatism, 2011
Systemic sclerosis (SSc; scleroderma) is a connective tissue disorder that is characterized by an obstructive vasculopathy and by the excessive deposition of collagen in the skin and internal organs.
G. Keyszer +7 more
semanticscholar +1 more source
Systemic sclerosis (SSc; scleroderma) is a connective tissue disorder that is characterized by an obstructive vasculopathy and by the excessive deposition of collagen in the skin and internal organs.
G. Keyszer +7 more
semanticscholar +1 more source
Progressive Systemic Sclerosis
The Nurse Practitioner, 1982Progressive systemic sclerosis is a disease of uncertain etiology associated with vascular/collagen tissue changes that may affect only the skin (scleroderma) or any and all internal organs (PSS). A disease primarily of Caucasian females, PSS is usually manifested in the fourth to sixth decade of life.
Linda B. Pearson, Linna Walker
openaire +3 more sources
Ketanserin in the Treatment of Progressive Systemic Sclerosis
Angiology, 1988Now progressive systemic sclerosis (PSS) is considered a disease of small vessels with which many immunologic alterations are associated. The presence in the blood of large amounts of serotonin can be considered a very important aggravating factor able to cause the sclerodermic alterations.
G. F. Altomare +2 more
openaire +3 more sources
Epidemiology of Progressive Systemic Sclerosis
Clinics in Rheumatic Diseases, 1979SUMMARY Although PSS may at times be difficult to distinguish from closely related disorders, especially early in its course, a characteristic set of cutaneous and visceral manifestations are helpful in differentiation. The cutaneous sclerosis characteristic of the disease varies in extent from classic diffuse (generalized) scleroderma to the ...
Thomas A. Medsger, Alfonse T. Masi
openaire +2 more sources
Anorectal abnormalities in progressive systemic sclerosis [PDF]
Diseases of the Colon & Rectum, 1989 Seventeen patients with progressive systemic sclerosis (PSS) were evaluated with manometry for anorectal function, and an additional 36 age-matched normal subjects were collected as a control group. The study group had a significant decrement of maximum basal pressure (MBP), 42.6 +/- 27.0 mm Hg, in PSS as compared with the control group, 71.2 +/- 24.9 ...
Jen-Kou Lin +2 more
openaire +2 more sources
Penicillamine and Progressive Systemic Sclerosis
Annals of Internal Medicine, 1983Excerpt To the editor: Steen and associates (1) have attempted to draw conclusions about the effect of D-penicillamine on the natural history of progressive systemic sclerosis with diffuse sclerode...
openaire +3 more sources